Latest Tax Rebates News

Great Dirt Resources has secured a significant exploration licence in the Pilbara lithium province and bolstered its finances with a $335,000 R&D tax rebate, setting the stage for accelerated exploration activities.

South Harz Potash Limited has launched a two-tranche placement and a rights issue to raise over A$3 million, aiming to accelerate development of its German potash assets amid mixed funding prospects.

Acrux Limited has secured a further $0.46 million advance on its FY25 R&D Tax Incentive, bringing total advances to $2.19 million and supporting its pharmaceutical product development and working capital needs.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

South Harz Potash Limited has launched a two-tranche equity raising to secure up to A$3.11 million, aiming to advance its dual-asset strategy and strengthen its position in the European potash market.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Algorae Pharmaceuticals has secured a significant A$318,771 R&D tax incentive rebate from the Australian Taxation Office, providing a non-dilutive cash injection to advance its AI-driven drug discovery programs.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Ardea Resources has received a $1.2 million R&D tax incentive rebate from the Australian Government, reinforcing its innovative work at the Kalgoorlie Nickel Project and strengthening its financial position.

Recce Pharmaceuticals reports strong Phase II clinical trial results for its topical anti-infective R327G, achieving a 93% efficacy rate in treating ABSSSI, alongside a significant capital raise to fund upcoming Phase III trials.

Environmental Clean Technologies Limited has commissioned batch-scale granulation equipment and produced its first 12 tonnes of COLDry Fertiliser, while securing $1.75 million in capital through placements and convertible notes to support ongoing project financing.

South Harz Potash Limited has progressed its Ohmgebirge project with key steps including advancing the Sollstedt mine acquisition, securing A$500,000 in new equity, and pursuing strategic funding avenues such as German R&D rebates and European Union grants.